benign prostatic hyperplasia
Conditions
Interventions
A:Photoselective Vapo-Enucleation of the Prostate
B:Photoselective Vaporization of the Prostate
Sponsors
Department of Urology, Southwest Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients with benign prostatic hyperplasia combined with one of the following criteria can enter the study group: 1. Repeated urinary retention (at least one time after pulling out the catheter cannot be voided or two urinary retention); 2. Repeated hematuria, drug treatment is ineffective; 3. Recurrent urinary tract infection; 4. bladder calculi; 5. Secondary hydronephrosis (with or without renal impairment); 6. Combined with inguinal hernia, severe hemorrhoids or rectocele, and it is difficult to achieve therapeutic effect without removing urinary tract obstruction.
Exclusion criteria
Exclusion criteria: 1. Patients with progressive malignant tumor; 2. Diuretic muscle contractions are weak; 3. Combined with urethral stricture; 4. The combination of uncontrolled urinary tract infection causes bladder urethral dysfunction; 5. The combination of central or peripheral neuropathy causes bladder urethral dysfunction; 6. Patients with severe heart and lung disease cannot tolerate surgery and anesthesia; 7. Patients with coagulopathy; 8. Patients with mental disorders; 9. Patients who are considered unfit to participate in any other condition of the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum flow rate (QMax);Inter-national Prostate Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| post-void residual urine volume;prostate volume;prostate specific antigen;International Index of Erectile Function;Quality Of Life Score;operation duration;OABq-SF health;OABq-SF health;International Consulta-tion on Incontinence Questionnaire Short Form;Amount of bleeding in operation; | — |
Countries
China
Contacts
Public ContactShen Wenhao
Department of Urology, Southwest Hospital
Outcome results
None listed